Wealthedge Investment Advisors »

Biogen Idec shares owned by Wealthedge Investment Advisors

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Wealthedge Investment Advisors from 13F filings

Historical chart of Wealthedge Investment Advisors investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Wealthedge Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Wealthedge Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $530k 3.9k 136.84
2024-12-31 $265k 1.7k 152.92

More positions owned by Wealthedge Investment Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Microsoft Corporation (MSFT)
Agf Invts Tr Us Market Netrl (BTAL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHP)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Russell 2000 Etf (IWM)
Bristol Myers Squibb (BMY)

View all positions for Wealthedge Investment Advisors

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Point72 Asset Management
Wellington Management Company
Geode Capital Management
Invesco
Susquehanna International
AQR Capital Management
Legal & General Group
Northern Trust
Millennium Management
Ubs Global Asset Management Americas
Barclays

View all funds holding Biogen Idec